Review Article

Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases

Table 5

Urinary candidate biomarkers for AKI.

Protein biomarkersUp/downregulationCohortTechniqueType of biomarkerReference

IL-18AKI after CBP (), controls ()ELISAPredictive[129]

KIM-1, NAG, and NGALAKI (), early AKI (), late AKI (), and non-AKI ()ELISAPredictive[130]

Aprotinin106 pediatric patients undergoing CPBSELDI-TOF-MSPredictive[110]

NGAL71 children undergoing cardiopulmonary bypassWestern blot and ELISAPredictive[131]

KIM-1Cisplatin-induced nephrotoxic rats ()ELISAPredictive[132]

Albumin, α-1-antitrypsin, and β-2-microglobulinAKI () and non-AKI () from ICU patients as training set, AKI () and non-AKI () from ICU patients, and AKI () and non-AKI () from HSCT patients as validation setCE-MSDiagnostic[111]

Fibrinogen α and collagens 1α(I) and 1α(III)CE-MSDiagnostic[111]

Zinc-alpha-2-glycoprotein and a fragment of adrenomedullin-binding proteinDiscovery cohort: AKI () and non-AKI (); validation cohort: AKI () and non-AKI ()2D-DIGE and MALDI-TOF-MS and validation by ELISA and western blotPredictive[112]

IGFBP-7 and NGALLNR (), ER (), and control ()2D-DIGE and validation by ELISADiagnostic/prognostic[113]

Netrin-1AKI (), non-AKI ()ELISAPredictive[133]

α1-microglobulin, α1-acid glycoprotein, and albuminDiscovery cohort: AKI () and control (); validation cohort: AKI () and control ()SELDI-TOF-MS and validation by nephelometryDiagnostic/prognostic[134]

Hsp72AKI (), control ()ELISAPredictive[135]